Many With Cancer Hospitalized, Undergo Imaging at End of Life

This article originally appeared here.
Share this content:
Many With Cancer Hospitalized, Undergo Imaging at End of Life
Many With Cancer Hospitalized, Undergo Imaging at End of Life

WEDNESDAY, July 26, 2017 (HealthDay News) -- About half of cancer patients are hospitalized and undergo at least one imaging scan at the end of life, according to a study published online July 24 in the Journal of Oncology Practice.

Cara L. McDermott, Pharm.D., Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues linked insurance claims to clinical information to examine indicators of high-quality end-of-life care. Patients aged ≥18 years with an invasive solid tumor with a recorded death date, who were enrolled in a commercial plan for the last month of life, and who made at least one insurance claim in the last 90 days of life were enrolled.

The researchers found that among 6,568 commercially insured patients, 56.3 percent were hospitalized and 48.6 percent underwent one or more imaging scans in the last month of life. Overall, 31.4 percent of patients younger than 65 years were enrolled in hospice; 40.5 percent of those not enrolled in hospice had received an opioid prescription. Among young adults not enrolled in hospice, opioid use in the last 30 days of life decreased over time, from 44.7 percent in 2007 to 2009 to 42.5 percent in 2010 to 2012, and to 36.7 percent in 2013 to 2015.

"Our findings suggest that policies that facilitate appropriate imaging, opioid, and hospice use and that encourage supportive care may improve end-of-life care and quality of life," the authors write.

One author disclosed financial ties to the pharmaceutical industry, and second author disclosed ties to a company that provides virtual care.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »